Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001513162-17-000104

President and CEO acquired 5,995 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BERMAN ROBERT ANDREW · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-04-03 Option exercise : show line 1 in the form +5,995 $2.38 $14,268 51,553 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-04-03 Option exercise : show line 2 in the form Subscription Right −5,995 0 D
Loading xslF345X03/primary_doc.xml…